Tokyo, Japan

Yoshimi Arima

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fujita Academy, Keio University, Kumamoto University. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimi Arima. Retrieved from https://idiyas.com/inventor/yoshimi-arima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Yoshimi Arima

Introduction

Yoshimi Arima is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of medical science, particularly in the area of stem cell research and therapeutic agents.

Latest Patents

Yoshimi Arima holds two patents that showcase her innovative work. The first patent is titled "Cell and utilization thereof," which provides an epithelial tissue stem cell derived from an adult that lacks at least one tumor suppressor gene. The second patent is for a "Prophylactic and/or therapeutic agent for dysmenorrhea," which discloses a therapeutic agent for dysmenorrhea and associated symptoms, specifically comprising tranilast as an active ingredient.

Career Highlights

Throughout her career, Yoshimi has worked with esteemed institutions such as Fujita Academy and Kumamoto University. Her research has focused on developing solutions that address significant health issues, demonstrating her commitment to advancing medical science.

Collaborations

Yoshimi has collaborated with notable colleagues, including Hideyuki Saya and Takashi Semba. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Yoshimi Arima's work exemplifies the impact of innovation in medical research. Her patents reflect her dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…